TP53 and malignant colon neoplasm: Loss of uL3 in p53-deleted colon cancer cells was associated with characteristic invasive phenotype with EMT and correlated with the development of resistance to different chemotherapeutic agents commonly used in clinic for the treatment of colon cancer as 5-FU [9,10,15].